The efficacy and safety of anti-TNFα treatment in ankylosing spondylitis patients with late onset compared to those with adult onset; the data from TURKBIO registry

Uslu, SadettinCan, GerçekCefle, AyşeYılmaz, SemaKocaer, Sinem Burcuİnel, Tuba YüceGülle, SemihKoca, Süleyman SerdarYolbaş, ŞervetÖztürk, Mehmet AkifŞenel, Sonerİnanc, NevsunDalkılıç, EdizGündüz, ÖzgülTufan, AbdurrahmanAkar, ServetBirlik, MerihSarı, İsmailAkkoç, NurullahÖnen, Fatoş2024-07-102024-07-102019-10-012326-5191https://hdl.handle.net/11452/43129Bu çalışma, 08-13, Kasım 2019 tarihlerinde Atlanta[Amerika]’da düzenlenen Annual Meeting of the American-College-of-Rheumatology/Association-of-Rheumatology-Professionals (ACR/ARP) Kongresi‘nde bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessRheumatologyThe efficacy and safety of anti-TNFα treatment in ankylosing spondylitis patients with late onset compared to those with adult onset; the data from TURKBIO registryMeeting Abstract00050746690238571Supplement 10